Press release
Europe Autoimmune Hemolytic Anemia Therapeutics Market to hit US$ 309.7 million by 2031: Industry Overview & Growth Prospects | Zenas BioPharma, Johnson & Johnson Services, Inc., Agios Pharmaceuticals, Inc, Novartis AG, Hoffmann-La Roche Limited
Europe Autoimmune Hemolytic Anemia Therapeutics Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/europe-autoimmune-hemolytic-anemia-therapeutics-market?kb
Europe: Recent Industry Developments
✅ November 2025: Roche announced positive Phase III trial results for a novel complement inhibitor targeting warm autoimmune hemolytic anemia.
✅ October 2025: European Medicines Agency (EMA) approved a biosimilar rituximab for improved access to first-line therapies.
✅ September 2025: Innovative oral therapies showed promising efficacy in reducing hemolysis in clinical studies across Germany and France.
Major Growing Players:
Sanofi, Grifols, Apellis Pharmaceuticals, Inc., Rigel Pharmaceuticals, Inc., Zenas BioPharma, Johnson & Johnson Services, Inc., Agios Pharmaceuticals, Inc, Novartis AG, Hoffmann-La Roche Limited and Incyte
Latest M&A
1. Recordati acquired Enjaymo (Sanofi's sutimlimab) global rights for CAD to bolster rare diseases portfolio ($825M, Oct 2024).
2. BMS acquired Asian market rights to obexelimab from Zenas BioPharma, expanding AIHA pipeline (Sep 2023).
3. Sanofi and Novartis maintain active development pipelines with strategic partnerships, leveraging AI and monoclonal antibody platforms for next-generation AIHA treatments.
Forecast Projection:
The Europe Autoimmune Hemolytic Anemia Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Europe Autoimmune Hemolytic Anemia Therapeutics Market report is built on solid intelligence - powered by both primary and secondary research. Our analysts have deep-dived into every factor that can influence your business roadmap, including government regulations, competitive landscape, tech innovations, historical market behavior, upcoming breakthroughs, adjacent industry trends, market volatility, growth prospects, and potential risks.
Government Regulations and FDA Approvals
1. FDA approved nipocalimab (IMAAVYTM), an FcRn blocker, in July 2025 for warm AIHA; granted orphan drug and breakthrough therapy designations for multiple autoimmune indications.
2. EMA follows stringent regulation on safety and pharmacovigilance for novel immunotherapies and complement inhibitors for AIHA and CAD.
3. Guideline updates emphasize early biological intervention and monitoring frameworks for hemolysis markers and immune response modulation.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=europe-autoimmune-hemolytic-anemia-therapeutics-market?kb
Key Segments:
By Drug Class: (Corticosteroids, Monoclonal Antibodies, Others)
By Route of Administration: (Oral, Injectable), By Therapy Type (First Line Therapy, Second Line Therapy, Third Line Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Pharmacy), By Disease Type (Cold Antibody Hemolytic Anemia, Warm Antibody Hemolytic Anemia)
Benefits of the Report:
Chapter 1: sets the stage by defining the full scope of the report and delivering an executive summary of key market segments across regions, product types, and applications. It provides a comprehensive snapshot of current market sizes and reveals future growth potential, offering a clear vision of how the market will evolve in the short, mid, and long term.
Chapter 2: uncovers critical insights and highlights the most impactful emerging trends shaping the Europe Autoimmune Hemolytic Anemia Therapeutics market's future - essential knowledge for investors and strategists looking to stay ahead.
Chapter 3: dives deep into the competitive landscape, delivering an in-depth analysis of Europe Autoimmune Hemolytic Anemia Therapeutics manufacturers. It covers market share dynamics, strategic developments, and the latest mergers and acquisitions that are redefining the industry.
Chapter 4: profiles the market's leading players, offering detailed views of their revenue streams, profit margins, product portfolios, and recent innovations - arming you with the intel to benchmark and strategize effectively.
Chapters 5 & 6: break down revenue performance by region and country, providing a quantitative analysis that spotlights growth hotspots, development prospects, and the unique opportunities each market offers across the globe.
Chapter 7: explores market segmentation by type, revealing the size and untapped potential of each segment - guiding you toward lucrative "blue ocean" opportunities that competitors may have overlooked.
Chapter 8: analyzes the market by application, evaluating downstream sectors with the highest growth potential and identifying promising areas for expansion and investment.
Chapter 9: maps the entire industry supply chain, tracing upstream suppliers to downstream distributors, giving you full visibility into critical business linkages and value drivers.
Chapter 10: wraps up with a powerful summary of the report's key findings and strategic takeaways, delivering the must-know insights every industry stakeholder needs to make confident, forward-looking decisions.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/europe-autoimmune-hemolytic-anemia-therapeutics-market?kb
Supply Chain
1. Manufacturing centers for monoclonal antibodies and complement inhibitors concentrated in US and Europe; stringent GMP practices mandatory.
2. Supply chain tightening from specialty drug complexity, especially biologics' cold chains and validated sterile manufacturing.
3. Increasing reliance on contract manufacturing organizations (CMOs) with advanced capabilities to mitigate risks and ensure global distribution continuity.
Have Detailed Enquiry of This Report @ https://www.datamintelligence.com/enquiry/europe-autoimmune-hemolytic-anemia-therapeutics-market?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Autoimmune Hemolytic Anemia Therapeutics Market to hit US$ 309.7 million by 2031: Industry Overview & Growth Prospects | Zenas BioPharma, Johnson & Johnson Services, Inc., Agios Pharmaceuticals, Inc, Novartis AG, Hoffmann-La Roche Limited here
News-ID: 4300610 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Global Organic Bakery Products Market is expected to reach US$ 147.5 billion by …
Global Organic Bakery Products Market reached US$ 73.5 billion in 2022 and is expected to reach US$ 147.5 billion by 2031, growing with a CAGR of 9.1% during the forecast period 2024-2031.
Increasing consumer focus on health and wellness trends is increasing their demand for clean-label products that are free from harmful chemicals and pesticides. The increasing support and promotional activities for organic products from governments, celebrities and social media influencers…
Tungsten-Based Materials Recycling Market is expected to reach US$ 1,363.6 milli …
Global Tungsten-Based Materials Recycling Market reached US$ 799.2 million in 2023 and is expected to reach US$ 1,363.6 million by 2031, growing with a CAGR of 7.1% during the forecast period 2024-2031.
Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/tungsten-based-materials-recycling-market?pratik
The demand for essential metals, such as tungsten, is rising owing to the global transition towards Electric Car and renewable energy technology. Recycling techniques are being adopted to…
Chronic Lower Back Pain Drugs Market 2025: Key Players, Drug Development & Marke …
Chronic Lower Back Pain Drugs Market reached US$ 2,768.82 million in 2024 and is expected to reach US$ 4,608.47 million by 2033, growing at a CAGR of 6.4% during the forecast period of 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/chronic-lower-back-pain-drugs-market?kb
United States: Recent Industry Developments
✅ November 2025: FDA approved a novel non-opioid analgesic showing significant efficacy in managing chronic lower back pain…
Vital Signs Monitoring Devices Market is expected to reach US$ 11.12 Billion by …
The global vital signs monitoring devices market reached US$ 5.35 Billion in 2023, with a rise of US$ 5.73 Billion in 2024 and is expected to reach US$ 11.12 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
The global vital signs monitoring devices market is expanding due to demographic, technological, and healthcare trends. Chronic diseases like hypertension, diabetes, and cardiovascular disorders are increasing, leading to…
More Releases for Europe
2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends
Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging…
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business.
A new report as a Digital Strategy Consulting market that includes a comprehensive analysis…
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• McKinsey
• The Boston Consulting Group
• Bain & Company
• Booz & Co.
• Roland Berger Europe
• Oliver Wyman Europe
• A.T. Kearney Europe
• Deloitte
• Accenture Europe
Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB
Market segment by Type, the product can be split into
• Operations Consultants
• Business Strategy Consultants
• Investment Consultants
• Sales and…
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage.
The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China.
In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
